Suppr超能文献

单核细胞/巨噬细胞纤溶酶原激活物活性表达的调节及其对血管病变减轻的影响

Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.

作者信息

Lundgren C H, Sawa H, Sobel B E, Fujii S

机构信息

Cardiovascular Division, Washington University School of Medicine, St Louis, MO 63110.

出版信息

Circulation. 1994 Oct;90(4):1927-34. doi: 10.1161/01.cir.90.4.1927.

Abstract

BACKGROUND

The binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR) on cell surfaces has the potential to influence degradation of extracellular matrix (ECM). Thus, uPA bound to monocyte/macrophages and its interactions with plasminogen activator inhibitors types 1 and 2 (PAI-1 and PAI-2) may modify atherogenesis by altering cell-associated proteolytic activity, degradation of ECM, and neointimal formation at sites of vascular injury.

METHODS AND RESULTS

To determine whether the expression of proteins on the surface of cells involved in fibrinolysis changes in human cells in response to mediators implicated in atherogenesis, we exposed U937 cells (an immortal human monocyte-like cell line) to transforming growth factor-beta (TGF-beta) and to thrombin. Induction of uPAR mRNA occurred with TGF-beta (5 ng/mL) in a time-dependent fashion (P = .05; n = 4). Thrombin (5 National Institutes of Health [NIH] U/mL) increased uPAR mRNA by 2.8-fold above control (n = 4) without altering PAI-1 mRNA or protein synthesis (n = 4). The increase in uPAR gene expression in cells exposed to either TGF-beta or thrombin translated into a functional increase in cell-surface proteolytic activity. Under control conditions, U937 cells expressed PAI-2 but not PAI-1 mRNA. PAI-2 mRNA expression increased (P < .05; n = 4) with thrombin (5 NIH U/mL) but was suppressed by TGF-beta (5 ng/mL). TGF-beta induced PAI-1 mRNA within 6 hours accompanied by a 9-fold increase in PAI-1 protein from 6 hours (2.9 +/- 1.9 ng/mL) to 24 hours (20.0 +/- 9.6 ng/mL, P = .005; n = 3) paralleled by increased synthesis as shown in metabolic labeling experiments with 35S-methionine and immunoprecipitation of labeled PAI-1. PAI-1 mRNA and protein expression were seen in human coronary artery atherectomy specimens as well and were localized to analogous monocyte/macrophages and to smooth muscle cells as judged from results of in situ hybridization and immunocytochemistry studies.

CONCLUSIONS

The results indicate that there is induction of PAI-1 and uPAR in U937 cells exposed to TGF-beta and thrombin. In atheroma, analogous processes may modulate early migration of luminal monocytes into the subintimal space and proteolysis of ECM. Thus, cell surface, monocyte-directed fibrinolysis may influence atherosclerosis, restenosis, or both.

摘要

背景

尿激酶型纤溶酶原激活剂(uPA)与细胞表面的受体(uPAR)结合,有可能影响细胞外基质(ECM)的降解。因此,与单核细胞/巨噬细胞结合的uPA及其与1型和2型纤溶酶原激活剂抑制剂(PAI - 1和PAI - 2)的相互作用,可能通过改变细胞相关的蛋白水解活性、ECM降解以及血管损伤部位的内膜形成来改变动脉粥样硬化的发生发展。

方法与结果

为了确定参与纤溶的细胞表面蛋白表达在人类细胞中是否会因动脉粥样硬化相关介质而发生变化,我们将U937细胞(一种永生的人类单核细胞样细胞系)暴露于转化生长因子 - β(TGF - β)和凝血酶。TGF - β(5 ng/mL)以时间依赖性方式诱导uPAR mRNA表达(P = 0.05;n = 4)。凝血酶(5美国国立卫生研究院[NIH]单位/mL)使uPAR mRNA比对照增加2.8倍(n = 4),而不改变PAI - 1 mRNA或蛋白合成(n = 4)。暴露于TGF - β或凝血酶的细胞中uPAR基因表达的增加转化为细胞表面蛋白水解活性的功能性增加。在对照条件下,U937细胞表达PAI - 2但不表达PAI - 1 mRNA。凝血酶(5 NIH单位/mL)使PAI - 2 mRNA表达增加(P < 0.05;n = 4),但被TGF - β(5 ng/mL)抑制。TGF - β在6小时内诱导PAI - 1 mRNA,同时PAI - 1蛋白从6小时(2.9±1.9 ng/mL)到24小时(20.0±9.6 ng/mL,P = 0.005;n = 3)增加9倍,这与用35S - 甲硫氨酸进行的代谢标记实验以及标记的PAI - 1的免疫沉淀所显示的合成增加平行。在人类冠状动脉粥样斑块切除标本中也观察到了PAI - 1 mRNA和蛋白表达,根据原位杂交和免疫细胞化学研究结果判断,它们定位于类似的单核细胞/巨噬细胞和平滑肌细胞。

结论

结果表明,暴露于TGF - β和凝血酶的U937细胞中PAI - 1和uPAR被诱导。在动脉粥样硬化斑块中,类似的过程可能调节管腔单核细胞早期迁移到内膜下空间以及ECM的蛋白水解。因此,细胞表面针对单核细胞的纤溶可能影响动脉粥样硬化、再狭窄或两者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验